SCHEMBL19851624

SCHEMBL19851624

c1ccc2oc(-c3ccc4[nH]cnc4c3)cc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.51
ALOX5 P09917 1/20 0.50
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HPGD P15428 2/20 0.49
TP53 P04637 1/20 0.49
MAOB P27338 4/20 0.49
MAOA P21397 3/20 0.47
PTPRC P08575 1/20 0.46
PTPN1 P18031 1/20 0.46
METAP2 P50579 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
RET P07949 1/20 0.41
MEN1 O00255 1/20 0.41
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19134465 0.89 KDM4E (0.63) ADRA2AALOX5NPC1RAB9AKDM4E
SCHEMBL22871240 0.81 APP (0.38) ADRA2AALOX5NPC1RAB9AKDM4E
SCHEMBL20121979 0.79 KDM4E (0.52) ADRA2AALOX5NPC1RAB9AKDM4E
SCHEMBL19368366 0.76 KDM4E (0.49) ADRA2AALOX5NPC1RAB9AKDM4E
SCHEMBL3695343 0.75 NPC1 (0.56) ADRA2AALOX5NPC1RAB9AKDM4E
SCHEMBL31143361 0.74 MAPT (0.50) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL6008269 0.74 MAPT (0.50) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL2457365 0.73 QPCT (0.50) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL2461139 0.73 ALK (0.44) RAB9AALDH1A1TP53MEN1KMT2A
SCHEMBL13201323 0.72 GSK3B (0.58) ALOX5NPC1RAB9AMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3573981-B1 ALKOXY BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB Biopharma SRL (BE) 2022-03-16 EP disclosed
EP-3328379-B1 BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB Biopharma SRL (BE) 2021-07-28 EP disclosed
EP-3573982-B1 BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB Biopharma SRL (BE) 2021-06-16 EP disclosed
EP-3573986-B1 BICYCLIC BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB Biopharma SRL (BE) 2021-05-26 EP disclosed
EP-3348556-B1 HETEROARYL AMIDES AS INHIBITORS OF PROTEIN AGGREGATION UCB Biopharma SRL (BE) 2020-04-29 EP disclosed
WO-2019191189-A1 COMPOUNDS AS MODULATORS OF TLR2 SIGNALING NEUROPORE THERAPIES, INC. (US) 2019-10-03 WO disclosed
WO-2018138088-A1 BICYCLIC BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB BIOPHARMA SPRL (BE) 2018-08-02 WO disclosed
WO-2018138086-A1 BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB BIOPHARMA SPRL (BE) 2018-08-02 WO disclosed
WO-2018138085-A1 ALKOXY BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB BIOPHARMA SPRL (BE) 2018-08-02 WO disclosed
EP-3099684-B1 HETEROARYL AMIDES AS INHIBITORS OF PROTEIN AGGREGATION NEUROPORE THERAPIES INC (US) 2018-04-04 EP disclosed
WO-2018026866-A1 LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION NEUROPORE THERAPIES, INC. (US) 2018-02-08 WO disclosed